paclitaxel has been researched along with Liver Diseases in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (40.00) | 18.2507 |
| 2000's | 3 (30.00) | 29.6817 |
| 2010's | 3 (30.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, N; Chopra, R; Li, Y; Palmisano, M; Ye, Y; Zhou, S | 1 |
| Eren, B; Karaduman, D; Keles, ON | 1 |
| Bhar, P; Biakhov, MY; Desai, N; Iglesias, J; Kononova, GV; Loibl, S; Schmid, AN | 1 |
| Beijnen, JH; de Graeff, A; Huitema, AD; Huizing, MT; Joerger, M; Rosing, H; Schellens, JH; Vermorken, JB; Willemse, PH | 1 |
| Fujita, H; Kojima, H; Mase, H; Okamoto, M; Takao, A | 1 |
| Beijnen, JH; De Graeff, A; Huizing, MT; Panday, VR; ten Bokkel Huinink, WW; Vermorken, JB; Willemse, PH | 1 |
| Crosignani, A; D'Incalci, M; Donelli, MG; Munzone, E; Zucchetti, M | 1 |
| Clarke, SJ; Rivory, LP | 1 |
| Blesch, K; Reigner, B; Weidekamm, E | 1 |
| Samur, M | 1 |
5 review(s) available for paclitaxel and Liver Diseases
| Article | Year |
|---|---|
Pharmacokinetics and pharmacodynamics of nab-paclitaxel in patients with solid tumors: disposition kinetics and pharmacology distinct from solvent-based paclitaxel.
Topics: Adult; Aged; Aged, 80 and over; Albumins; Antineoplastic Agents, Phytogenic; Dose-Response Relationship, Drug; Female; Humans; Liver Diseases; Logistic Models; Male; Middle Aged; Models, Biological; Neoplasms; Neutropenia; Nonlinear Dynamics; Paclitaxel; Young Adult | 2014 |
Hepatic metabolism of paclitaxel and its impact in patients with altered hepatic function.
Topics: Animals; Antineoplastic Agents, Phytogenic; Humans; Liver; Liver Diseases; Paclitaxel | 1997 |
Pharmacokinetics of anticancer agents in patients with impaired liver function.
Topics: Anthracyclines; Antimetabolites, Antineoplastic; Antineoplastic Agents; Cyclophosphamide; Dose-Response Relationship, Drug; Doxorubicin; Humans; Liver Diseases; Paclitaxel; Podophyllotoxin; Vinca Alkaloids | 1998 |
Clinical pharmacokinetics of docetaxel.
Topics: Animals; Antineoplastic Agents, Phytogenic; Child; Clinical Trials as Topic; Docetaxel; Drug Interactions; Forecasting; Humans; Kidney Diseases; Liver Diseases; Paclitaxel; Protein Binding; Taxoids | 1999 |
Clinical pharmacokinetics of capecitabine.
Topics: Antacids; Antimetabolites, Antineoplastic; Capecitabine; Colorectal Neoplasms; Deoxycytidine; Docetaxel; Dose-Response Relationship, Drug; Drug Interactions; Fluorouracil; Food; Humans; Intestinal Absorption; Leucovorin; Liver Diseases; Paclitaxel; Protein Binding; Taxoids | 2001 |
1 trial(s) available for paclitaxel and Liver Diseases
| Article | Year |
|---|---|
nab-Paclitaxel in patients with advanced solid tumors and hepatic dysfunction: a pilot study.
Topics: Adult; Aged; Albumins; Antineoplastic Agents, Phytogenic; Female; Humans; Liver Diseases; Male; Middle Aged; Neoplasm Metastasis; Neoplasms; Paclitaxel; Pilot Projects | 2010 |
4 other study(ies) available for paclitaxel and Liver Diseases
| Article | Year |
|---|---|
The protective effect of beta-1,3-D-glucan on taxol-induced hepatotoxicity: a histopathological and stereological study.
Topics: Animals; Antioxidants; beta-Glucans; Chemical and Drug Induced Liver Injury; Drug-Related Side Effects and Adverse Reactions; Free Radical Scavengers; Gastrointestinal Diseases; Glucans; Liver; Liver Diseases; Mice; Necrosis; Oxidative Stress; Paclitaxel; Proteoglycans; Rats; Rats, Sprague-Dawley; Rats, Wistar | 2010 |
Safety and pharmacology of paclitaxel in patients with impaired liver function: a population pharmacokinetic-pharmacodynamic study.
Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Bilirubin; Biomarkers; Cohort Studies; Dose-Response Relationship, Drug; Female; Humans; Liver Diseases; Liver Function Tests; Male; Middle Aged; Paclitaxel; Sex Factors; Treatment Outcome | 2007 |
[Pharmacokinetics of paclitaxel in experimental animals. Part 2. Tissue distribution].
Topics: Animals; Carbon Tetrachloride Poisoning; Chemical and Drug Induced Liver Injury; Female; Half-Life; Injections, Intravenous; Liver Diseases; Male; Mice; Mice, Inbred ICR; Paclitaxel; Rabbits; Sarcoma 180; Tissue Distribution | 1994 |
Docetaxel and liver dysfunction: is it absolutely contraindicated?
Topics: Antineoplastic Agents, Phytogenic; Contraindications; Docetaxel; Female; Humans; Liver Diseases; Middle Aged; Paclitaxel; Taxoids | 2001 |